Hospice CareNCT06408090
Underutilization of Hospice Care in Older Black Adults
A study testing IDECIDE-HOSPICE in people with Hospice Care and Decision Aid, run by University of Colorado, Denver at 1 site in United States.
Trial summary
This study will sample older Black adults to test their knowledge and opinions of hospice. Read more about this study
- Who is it for?
- Ages 65 to 99 yearsHealthy volunteers can take part
- Conditions the study is for
- Hospice Care, Decision Aid, Decision-Making
- What is being tested?
- IDECIDE-HOSPICE
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 400 participants
- Where
- 1 siteUnited States
- Study dates
- 2 Jun 2023to 1 Jun 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 to 99 years
- All sexes
- Healthy volunteers accepted
- Older adult
Who may be able to join
- Identifies as Black or African American
- Can read and write English
Who cannot join
- Unable to read/write English
- Have a cognitive impairment that prevents them from providing informed consent
Trial locations and contacts
1 site in 1 country.
United States1 site
University of Colorado Denver | Anschutz Medical Campus
Aurora, Colorado, 80045
About this study
Official title: Knowledge of and Attitudes Toward Hospice, Decision-making Around Hospice in Older Black Adults
This study will sample older Black adults to test their knowledge and opinions of hospice.
Read the detailed description
Short stays in hospice strain the Medicare system. Black adults over age 65 are one of the fastest growing groups in the US. Despite greater disease burden than their White peers, older Black adults are less likely to enroll in hospice. Misconceptions about hospice and mistrust may contribute to this disparity. The research will seek to understand older Black adults' decision-making processes around hospice. The PtDA is a tool to assist in this decision-making process. The influence of this tool will be measured as well. The sample of older Black adults will represent the national population. The research will explore various subgroups, which previous research has been unable to address. This study will use four validated survey batteries. About 200 of the 400 participants will also review the decision aid. These adults will complete a second survey. About 20 of these adults will also complete an interview about the decision aid. Through the surveys and interviews, this research will explore barriers to hospice usage for older Black adults.
- Conditions
- Hospice Care, Decision Aid, Decision-Making, Aging, Knowledge, Attitude
- Being tested
- IDECIDE-HOSPICE
- Medical subject headings
- Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
IDECIDE-HOSPICEOther
Also called PtDA
12-pg educational booklet detailing information about hospice including what hospice is, why someone would use hospice, who pays for hospice, and where hospice services are delivered
| Study group | Role | What they receive |
|---|---|---|
| Intervention | Experimental | 200 participants reviewed the PtDA decision tool for education on hospice care and subsequently completed a second survey which was identical to the first. Receives: Other: IDECIDE-HOSPICE |
| Interview | Other | 20 of the 200 Intervention participants will complete an interview using qualitative methods surrounding the topic of hospice care and the PtDA. Receives: Other: IDECIDE-HOSPICE |
| Control | No intervention | 200 of the 400 participants completed two identical surveys one month apart but did NOT review the PtDA decision tool prior to completing the second survey timepoint. Instead, these participants reviewed an 8-page attention control activity booklet. These participants are used as a control group in assessing any change in knowledge or opinions of hospice after the intervention group reviewed the PtDA. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Hospice Knowledge
assessed using 23-item hospice knowledge survey
Measured: June 2023 through September 2023
Hospice Beliefs and Attitudes
measured using 8-item Hospice Beliefs and Attitudes Scale (HBAS)
Measured: June 2023 through September 2023
Self-Efficacy
assessed using 11-item Decision Self-Efficacy Scale (DSE)
Measured: June 2023 through September 2023
Secondary outcomes (1)
Medical Mistrust
measured using 17-item Medical Mistrust Index (MMI)
Measured: June 2023 through September 2023
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 May 2024
- Study start2 Jun 2023
- Primary completion30 Sep 2024 (estimated)
- Study completion1 Jun 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Hospice CareStudies of the same condition, open and under way.
- More trials run by University of Colorado, DenverThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 400 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Colorado, Denver
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Channing E Tate, PhD, MPH, Principal investigator, University of Colorado School of Medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06408090
- Sponsor's protocol ID
- 23-0899
- Status last verified
- May 2024
- First submitted
- 31 Oct 2023
- Last updated
- 9 May 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 May 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Knowledge of and Attitudes Toward Hospice, Decision-making Around Hospice in Older Black Adults
- ClinicalTrials.gov ID
- NCT06408090
- Acronym / sponsor ID
- 23-0899
- Conditions
- Hospice Care, Decision Aid, Decision-Making, Aging, Knowledge, Attitude
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 400 participants (actual)
- Lead sponsor
- University of Colorado, DenverUniversity, hospital or other
- Study start
- 2 Jun 2023 (actual)
- Primary completion
- 30 Sep 2024 (estimated)
- Study completion
- 1 Jun 2026 (estimated)
- First posted
- 9 May 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study will sample older Black adults to test their knowledge and opinions of hospice.
Detailed description
Short stays in hospice strain the Medicare system. Black adults over age 65 are one of the fastest growing groups in the US. Despite greater disease burden than their White peers, older Black adults are less likely to enroll in hospice. Misconceptions about hospice and mistrust may contribute to this disparity. The research will seek to understand older Black adults' decision-making processes around hospice. The PtDA is a tool to assist in this decision-making process. The influence of this tool will be measured as well. The sample of older Black adults will represent the national population. The research will explore various subgroups, which previous research has been unable to address. This study will use four validated survey batteries. About 200 of the 400 participants will also review the decision aid. These adults will complete a second survey. About 20 of these adults will also complete an interview about the decision aid. Through the surveys and interviews, this research will explore barriers to hospice usage for older Black adults.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Double blind (participant, investigator)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Intervention | Experimental | Other: IDECIDE-HOSPICE200 participants reviewed the PtDA decision tool for education on hospice care and subsequently completed a second survey which was identical to the first. |
| Interview | Other | Other: IDECIDE-HOSPICE20 of the 200 Intervention participants will complete an interview using qualitative methods surrounding the topic of hospice care and the PtDA. |
| Control | No intervention | –200 of the 400 participants completed two identical surveys one month apart but did NOT review the PtDA decision tool prior to completing the second survey timepoint. Instead, these participants reviewed an 8-page attention control activity booklet. These participants are used as a control group in assessing any change in knowledge or opinions of hospice after the intervention group reviewed the PtDA. |
Who may qualify
- Ages
- 65 to 99 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Older adult
Key inclusion criteria (2 listed)
- Identifies as Black or African American
- Can read and write English
Key exclusion criteria (2 listed)
- Unable to read/write English
- Have a cognitive impairment that prevents them from providing informed consent
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| IDECIDE-HOSPICEAlso: PtDA12-pg educational booklet detailing information about hospice including what hospice is, why someone would use hospice, who pays for hospice, and where hospice services are delivered | Other | Intervention, Interview |
Primary outcome
Hospice Knowledge
Time frame: June 2023 through September 2023
assessed using 23-item hospice knowledge survey
Hospice Beliefs and Attitudes
Time frame: June 2023 through September 2023
measured using 8-item Hospice Beliefs and Attitudes Scale (HBAS)
Self-Efficacy
Time frame: June 2023 through September 2023
assessed using 11-item Decision Self-Efficacy Scale (DSE)
1 secondary outcome
Medical Mistrust
Time frame: June 2023 through September 2023
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 May 2024.
Related trials for Hospice Care
Not yet recruitingObservational study
IN-TALK: Co-producing a Hospice Intimacy Support Toolkit in England
Communication About Intimacy Needs in Hospice and Palliative Care
Not yet recruiting
Inpatient Hospice Transitions Checklist
Dementia
Not yet recruiting
Integrating Rhythmical Massage in Palliative Care
Palliative Care, Health Services, Palliative Care
RecruitingObservational study
Prehospital Care of End-of-Life Patients by the Strasbourg Mobile Emergency and Resuscitation Service: A Qualitative Study of Healthcare Professionals' Experiences and Use of a Comfort Care Booklet
End-of-life Care, Palliative Care
Recruiting
CommunityRx-Dementia + Peer Navigation (CRxDpeer)
Alzheimer s Disease, Dementia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Channing E Tate, PhD, MPH principal investigator
University of Colorado School of Medicine
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing IDECIDE-HOSPICE in people with Hospice Care and Decision Aid, run by University of Colorado, Denver at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 9 May 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Hospice Knowledge (time frame: June 2023 through September 2023). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 May 2024.